<SEC-DOCUMENT>0001140361-23-038825.txt : 20230809
<SEC-HEADER>0001140361-23-038825.hdr.sgml : 20230809
<ACCEPTANCE-DATETIME>20230809164600
ACCESSION NUMBER:		0001140361-23-038825
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20230809
DATE AS OF CHANGE:		20230809

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DARLING INGREDIENTS INC.
		CENTRAL INDEX KEY:			0000916540
		STANDARD INDUSTRIAL CLASSIFICATION:	FATS & OILS [2070]
		IRS NUMBER:				362495346
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1230

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-13323
		FILM NUMBER:		231155905

	BUSINESS ADDRESS:	
		STREET 1:		5601 N MACARTHUR BLVD
		CITY:			IRVING
		STATE:			TX
		ZIP:			75038
		BUSINESS PHONE:		9727170300

	MAIL ADDRESS:	
		STREET 1:		5601 N MACARTHUR BLVD
		CITY:			IRVING
		STATE:			TX
		ZIP:			75038

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DARLING INTERNATIONAL INC
		DATE OF NAME CHANGE:	19931223

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bullock John
		CENTRAL INDEX KEY:			0001595347

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		251 O'CONNOR RIDGE BLVD.
		STREET 2:		SUITE 300
		CITY:			IRVING
		STATE:			TX
		ZIP:			75038
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
<headerData>
<submissionType>144</submissionType>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001595347</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>



</filerInfo>
</headerData>
<formData>
<issuerInfo>
<issuerCik>0000916540</issuerCik>
<issuerName>DARLING INGREDIENTS INC.</issuerName>
<secFileNumber>001-13323</secFileNumber>
<issuerAddress>
<com:street1>5601 N. MacArthur Blvd.</com:street1>
<com:city>Irving</com:city>
<com:stateOrCountry>TX</com:stateOrCountry>
<com:zipCode>75038</com:zipCode>
</issuerAddress>
<issuerContactPhone>972 281-4478</issuerContactPhone>
<nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Bullock John</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
<relationshipsToIssuer>
<relationshipToIssuer>EVP - Chief Strategy Officer</relationshipToIssuer>
</relationshipsToIssuer>
</issuerInfo>
<securitiesInformation>
<securitiesClassTitle>Common</securitiesClassTitle>
<brokerOrMarketmakerDetails>
<name>TD Ameritrade</name>
<address>
<com:street1>7801 Mesquite Bend Dr.</com:street1>
<com:street2>Suite 112</com:street2>
<com:city>Irving</com:city>
<com:stateOrCountry>TX</com:stateOrCountry>
<com:zipCode>75063</com:zipCode>
</address>
</brokerOrMarketmakerDetails>
<noOfUnitsSold>72454</noOfUnitsSold>
<aggregateMarketValue>4947159</aggregateMarketValue>
<noOfUnitsOutstanding>159491100</noOfUnitsOutstanding>
<approxSaleDate>08/10/2023</approxSaleDate>
<securitiesExchangeName>NYSE</securitiesExchangeName>
</securitiesInformation>
<securitiesToBeSold>
<securitiesClassTitle>Common</securitiesClassTitle>
<acquiredDate>03/10/2020</acquiredDate>
<natureOfAcquisitionTransaction>Compensation</natureOfAcquisitionTransaction>
<nameOfPersonfromWhomAcquired>Darling Ingredients, Inc.</nameOfPersonfromWhomAcquired>
<isGiftTransaction>N</isGiftTransaction>
<amountOfSecuritiesAcquired>8710</amountOfSecuritiesAcquired>
<paymentDate>03/10/2020</paymentDate>
<natureOfPayment>N/A as it was compensation</natureOfPayment>
</securitiesToBeSold>
<securitiesToBeSold>
<securitiesClassTitle>Common</securitiesClassTitle>
<acquiredDate>03/07/2019</acquiredDate>
<natureOfAcquisitionTransaction>Compensation</natureOfAcquisitionTransaction>
<nameOfPersonfromWhomAcquired>Darling Ingredients, Inc.</nameOfPersonfromWhomAcquired>
<isGiftTransaction>N</isGiftTransaction>
<amountOfSecuritiesAcquired>5516</amountOfSecuritiesAcquired>
<paymentDate>03/07/2019</paymentDate>
<natureOfPayment>N/A as it was compensation</natureOfPayment>
</securitiesToBeSold>
<securitiesToBeSold>
<securitiesClassTitle>Common</securitiesClassTitle>
<acquiredDate>03/07/2022</acquiredDate>
<natureOfAcquisitionTransaction>Compensation</natureOfAcquisitionTransaction>
<nameOfPersonfromWhomAcquired>Darling Ingredients, Inc.</nameOfPersonfromWhomAcquired>
<isGiftTransaction>N</isGiftTransaction>
<amountOfSecuritiesAcquired>23801</amountOfSecuritiesAcquired>
<paymentDate>03/07/2022</paymentDate>
<natureOfPayment>N/A as it was compensation</natureOfPayment>
</securitiesToBeSold>
<securitiesToBeSold>
<securitiesClassTitle>Common</securitiesClassTitle>
<acquiredDate>01/14/2022</acquiredDate>
<natureOfAcquisitionTransaction>Compensation</natureOfAcquisitionTransaction>
<nameOfPersonfromWhomAcquired>Darling Ingredients, Inc.</nameOfPersonfromWhomAcquired>
<isGiftTransaction>N</isGiftTransaction>
<amountOfSecuritiesAcquired>34427</amountOfSecuritiesAcquired>
<paymentDate>01/14/2022</paymentDate>
<natureOfPayment>N/A as it was compensation</natureOfPayment>
</securitiesToBeSold>
<nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
<noticeSignature>
<noticeDate>08/09/2023</noticeDate>
<signature>/s/ John Bullock</signature>
</noticeSignature>
</formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
